HOUSTON, TX, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced the publication of an independent, peer-reviewed study in The American Journal on Addictions titled “High-intensity transcranial alternating current stimulation for gambling disorder comorbidities with alcohol use disorders: A case report.” The study evaluated the safety and efficacy of Nexalin's 15 milliamp (mA) neurostimulation device in a patient diagnosed with both gambling disorder (GD) and alcohol use disorder (AUD).

LOS ANGELES, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises RCI Hospitality Holdings, Inc., (“RICK” or the "Company") (NYSE: RICK) investors of a class action on behalf of investors that bought securities between December 15, 2021 and September 16, 2025, inclusive (the “Class Period”). RCI investors have until November 20, 2025 to file a lead plaintiff motion.

LOS ANGELES, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The DJS Law Group reminds investors of a class action lawsuit against Baxter International Inc. (“Baxter” or “the Company”) (NYSE: BAX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of BAX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

LOS ANGELES, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Quanex Building Products Corporation, (“Quanex” or the “Company”) (NYSE: NX) investors of a class action on behalf of investors that bought securities between December 12, 2024 and September 5, 2025, inclusive (the “Class Period”). Quanex investors have until November 18, 2025 to file a lead plaintiff motion.

Initiative led by researchers in Australia and Japan aims to map cancer and immune interactions to advance precision oncology across the region PLEASANTON, Calif. and SYDNEY , Nov. 18, 2025 /PRNewswire/ -- 10x Genomics, Inc.

SALT LAKE CITY , Nov. 18, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has begun clinical evaluations for its Co-Dx™ PCR Flu A/B, COVID-19, RSV Test Kit. The clinical performance testing is expected to support a submission to the United States Food and Drug Administration ("FDA") for 510(k) clearance of the upper respiratory multiplex point-of-care test, and the Co-Dx PCR Pro™* instrument.

First Ever FAST Channel for the AAPI Community Now Live on Amazon Prime Video Studio Series and Films Plus JoySauce Originals — Available On Demand at JoySauce.TV , on YouTube and via Mobile Apps LOS ANGELES and SANTA MONICA, Calif. , Nov. 18, 2025 /PRNewswire/ -- JoySauce, a leading lifestyle company for "American Asians" and all fans of broader Asian pop culture, and Cineverse (Nasdaq: CNVS), a next-generation entertainment studio, today launched the JoySauce Network.

TytoCare's FDA-cleared home diagnostic technology will be integrated with Teladoc Health's Primary360 and 24/7 Care programs, expanding high-quality remote care capabilities in-home capabilities NEW YORK , Nov. 18, 2025 /PRNewswire/ -- TytoCare, the leading virtual care company enabling in-home, clinical-grade physical exams, today announces an integration with Teladoc Health (NYSE: TDOC), the global leader in virtual care. This collaboration integrates TytoCare's Home Smart Clinic with Teladoc Health's 24/7 Care and Primary360 primary care programs, using advanced home diagnostic technology to provide clinical insights to virtual care clinicians.

IRVINE, Calif. , Nov. 18, 2025 /PRNewswire/ -- A team from Knobbe Martens led medical device pioneer Masimo (NASDAQ: MASI) to a victory over Apple in a dispute involving Masimo's patented heart monitoring technology.

NEW YORK , Nov. 18, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in KBR, Inc. ("KBR, Inc." or the "Company") (NYSE: KBR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of KBR, Inc. investors who were adversely affected by alleged securities fraud between May 6, 2025 and June 19, 2025.

Kupcho surges to the top of the season-long standings showcasing exceptional resilience and clutch decision-making NAPLES, Fla. , Nov. 18, 2025 /PRNewswire/ -- Aon plc (NYSE: AON), a leading global professional services firm, and the LPGA Tour today announced Jennifer Kupcho as the winner of the 2025 Aon Risk Reward Challenge, securing the title in dramatic fashion during the final event of the regular season.

TEL AVIV, Israel , Nov. 18, 2025 /PRNewswire/ -- Arbe Robotics Ltd. (Nasdaq: ARBE) (TASE: ARBE), a global leader in perception radar solutions, today announced that Arbe management will be participating and meeting investors at the 14th Annual ROTH Technology Conference taking place at the Hard Rock Hotel, Times Square, New York City, on November 19, 2025.

LEHI, Utah and LOUISVILLE, Ky. , Nov. 18, 2025 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that Chief Executive Officer Matt Hawkins and Chief Financial Officer Steve Oreskovich will participate in three upcoming investor conferences: 8th Annual Evercore ISI HealthCONx Conference: Mr.

NEW YORK , Nov. 18, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Inspire Medical Systems, Inc. ("Inspire Medical Systems, Inc." or the "Company") (NYSE: INSP) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Inspire Medical Systems, Inc. investors who were adversely affected by alleged securities fraud between August 6, 2024 and August 4, 2025.

NEW YORK , Nov. 18, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Telix Pharmaceuticals Ltd. ("Telix Pharmaceuticals Ltd.

NEW YORK , Nov. 18, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in MoonLake Immunotherapeutics ("MoonLake" or the "Company") (NASDAQ: MLTX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of MoonLake investors who were adversely affected by alleged securities fraud between March 10, 2024 and September 29, 2025.

NEW YORK , Nov. 18, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Baxter International, Inc. ("Baxter International, Inc." or the "Company") (NYSE: BAX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Baxter International, Inc. investors who were adversely affected by alleged securities fraud between February 23, 2022 and July 30, 2025.

NEW YORK , Nov. 18, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in RCI Hospitality Holdings, Inc. ("RCI Hospitality Holdings, Inc." or the "Company") (NASDAQ: RICK) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of RCI Hospitality Holdings, Inc. investors who were adversely affected by alleged securities fraud between December 15, 2021 and September 16, 2025.

NEW YORK , Nov. 18, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Fortinet, Inc. ("Fortinet, Inc." or the "Company") (NASDAQ: FTNT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Fortinet, Inc. investors who were adversely affected by alleged securities fraud between November 8, 2024 and August 6, 2025.

NEW YORK , Nov. 18, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of DexCom investors who were adversely affected by alleged securities fraud between January 8, 2024 and September 17, 2025.